ATC code D01 Antifungals for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup D01 is part of the anatomical group D Dermatologicals.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QD01...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
D01A Antifungals for topical use
- D01AA01 Nystatin
- D01AA02 Natamycin
- D01AA03 Hachimycin
- D01AA04 Pecilocin
- D01AA06 Mepartricin
- D01AA07 Pyrrolnitrin
- D01AA08 Griseofulvin
- D01AA20 Combinations
- D01AC01 Clotrimazole
- D01AC02 Miconazole
- D01AC03 Econazole
- D01AC04 Clomidazole
- D01AC05 Isoconazole
- D01AC06 Tiabendazole
- D01AC07 Tioconazole
- D01AC08 Ketoconazole
- D01AC09 Sulconazole
- D01AC10 Bifonazole
- D01AC11 Oxiconazole
- D01AC12 Fenticonazole
- D01AC13 Omoconazole
- D01AC14 Sertaconazole
- D01AC15 Fluconazole
- D01AC16 Flutrimazole
- D01AC20 Combinations
- D01AC52 Miconazole, combinations
- D01AC60 Bifonazole, combinations
- QD01AC90 Enilconazole
D01AE Other antifungals for topical use
- D01AE01 Bromochlorosalicylanilide
- D01AE02 Methylrosaniline
- D01AE03 Tribromometacresol
- D01AE04 Undecylenic acid
- D01AE05 Polynoxylin
- D01AE06 2-(4-chlorphenoxy)-ethanol
- D01AE07 Chlorphenesin
- D01AE08 Ticlatone
- D01AE09 Sulbentine
- D01AE10 Ethyl hydroxybenzoate
- D01AE11 Haloprogin
- D01AE12 Salicylic acid
- D01AE13 Selenium sulfide
- D01AE14 Ciclopirox
- D01AE15 Terbinafine
- D01AE16 Amorolfine
- D01AE17 Dimazole
- D01AE18 Tolnaftate
- D01AE19 Tolciclate
- D01AE20 Combinations
- D01AE21 Flucytosine
- D01AE22 Naftifine
- D01AE23 Butenafine
- D01AE54 Undecylenic acid, combinations
- QD01AE91 Bronopol
- QD01AE92 Bensuldazic acid
D01B Antifungals for systemic use
D01BA Antifungals for systemic use
- D01BA01 Griseofulvin
- D01BA02 Terbinafine
References
|
Antifungals (D01 and J02) |
|
Wall/
membrane |
|
|
|
|
|
|
topical: Bifonazole, Clomidazole, Clotrimazole#, Croconazole, Econazole, Fenticonazole, Ketoconazole, Isoconazole, Miconazole#, Neticonazole, Oxiconazole, Sertaconazole, Sulconazole, Tioconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intracellular |
|
|
| Others |
|
|
#WHO-EM. ‡Withdrawn from market. CLINICAL TRIALS: †Phase III. §Never to phase III
see also diseases |
|
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
